Radiopharmaceutical therapy is emerging as a safe and effective targeted approach to treating many types of cancer. Clinical trials for these therapies are complex requiring a multi-disciplinary approach and careful coordination to produce meaningful and conclusive results.
In this webinar, we look at the history and future trajectory of radiopharmaceuticals, describe their potential advantages, examine challenges specific to the development of these therapies, and identify key considerations for clinical trials, from meeting regulatory demands to recruiting patients. Topics include:
- How radiopharmaceuticals have evolved since 1903, when Alexander Graham Bell introduced the idea of placing radium-containing sources in or near tumors
- What’s ahead: advances in production and availability of new isotopes, new imaging technologies, discovery of new targets, and more
- Regulatory requirements, which differ considerably depending on geography
- Patient recruitment: overcoming misconceptions about exposure to radioactivity and management of travel for site visits and study assessments
Featured Speakers:
Rupa Doshi, Ph.D.
Vice President, Oncology Strategy
Ashley Herrick, Ph.D.
Executive Director, Program Strategy